SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007877
Filing Date
2022-05-05
Accepted
2022-05-05 16:32:25
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20220331.htm   iXBRL 10-Q 2342512
2 EX-10.2 lbph-ex10_2.htm EX-10.2 79755
3 EX-10.3 lbph-ex10_3.htm EX-10.3 130056
4 EX-31.1 lbph-ex31_1.htm EX-31.1 21053
5 EX-31.2 lbph-ex31_2.htm EX-31.2 21065
6 EX-32.1 lbph-ex32_1.htm EX-32.1 21767
7 GRAPHIC img8591006_0.jpg GRAPHIC 388322
8 GRAPHIC img141511159_0.jpg GRAPHIC 117730
9 GRAPHIC img142434680_0.jpg GRAPHIC 117730
  Complete submission text file 0000950170-22-007877.txt   10261598

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20220331.xsd EX-101.SCH 43788
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20220331_lab.xml EX-101.LAB 394344
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20220331_cal.xml EX-101.CAL 37895
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20220331_pre.xml EX-101.PRE 299295
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20220331_def.xml EX-101.DEF 161004
61 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20220331_htm.xml XML 1939251
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 22896930
SIC: 2834 Pharmaceutical Preparations